Main Menu
Collecting data in primary care can be a challenge. AbSPORU’s innovative approaches to research allow us to partner in the development of unique methods for recruitment and data collection in primary care for pragmatic trials. AbSPORU proudly supported four pragmatic trials on the timing of blood pressure medication, including the BedMed Trials, led by Dr. Scott Garrison from the University of Alberta.
The BedMed clinical trials are among the largest ever done in Canadian primary care, spanning 5 provinces: Alberta, BC, Saskatchewan, Manitoba, and Ontario.
These trials are showing that data collection across primary care sites and clinics can be cost effective and achievable on a large scale. We are pleased to share recent articles outlining the findings from the groundbreaking BedMed Trials, as presented by Dr. Garrison at the European Society of Cardiology Congress in August 2024.
Article: Cardiovascular Research Foundation
New BedMed Data Confirm Antihypertensives Can Be Taken Any Time of Day
Read Article
Article: European Society of Cardiology
Evening vs. morning dosing of blood pressure medication: no differences seen
Read Article
Article: BMJ Open
Bedtime versus morning use of antihypertensives for cardiovascular risk reduction (BedMed): protocol for a prospective, randomised, open-label, blinded end-point pragmatic trial
Read Article
Article: Canadian Institutes of Health Research
Study: reducing heart attack and stroke rates thanks to data analysis and patient involvement
Read Article
Better at bedtime? Why a Canadian study is testing a novel approach to blood pressure medication
Read Article
The Alberta SPOR SUPPORT Unit (AbSPORU) provides expertise, training and resources to the health research community to increase capacity for patient-oriented research. To learn more about AbSPORU’s involvement in the BedMed Trials, read our Story of Impact.
To learn more about the BedMed Study visit https://bedmedstudy.ca/
Let us know how you want to stay connected
© 2024 AbSPORU